A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio (original) (raw)

Improving Radioimmonotargeting of Tumors: Variation in the Amount of L6 Mab Administered, Combined with an Immunoadsorption System (Ecia)

Sven-erik Strand

Acta Oncologica, 1993

View PDFchevron_right

Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption

Michael Ljungberg

Medical & Biological Engineering & Computing, 1994

View PDFchevron_right

Enhancement of Tumor-to-NontumorLocalization Ratios by Hepatocyte-Directed Blood Clearance of Antibodies Labeled with CertainResidualizing Radiolabels

sagar patel

View PDFchevron_right

Systemic perfusion: a method of enhancing relative tumor uptake of radiolabeled monoclonal antibodies

Onelio Geatti

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988

View PDFchevron_right

Extracorporeal Adsorption Therapy: A Method to Improve Targeted Radiation Delivered by Radiometal-Labeled Monoclonal Antibodies

Ajay gopal

Cancer Biotherapy & Radiopharmaceuticals, 2008

View PDFchevron_right

Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor

Otto Boerman

Cancer Immunology Immunotherapy, 1992

View PDFchevron_right

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors

Otto Boerman

International Journal of Cancer, 1992

View PDFchevron_right

Improving tumor‐to‐normal‐tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin‐biotin concept

Sven-erik Strand

Cancer, 1997

View PDFchevron_right

Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation

Surinder Batra

Clinical Cancer Research, 2007

View PDFchevron_right

Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor

Lev Ivanov

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994

View PDFchevron_right

Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies

Julia Malamitsi

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1988

View PDFchevron_right

Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins

C. Meares

European Journal of Nuclear Medicine, 1984

View PDFchevron_right

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic study

Otto Boerman

Cancer Immunology Immunotherapy, 1991

View PDFchevron_right

Biological considerations for radioimmunotherapy

roz blumenthal

Cancer research, 1990

View PDFchevron_right

Kinetics of Radioiodinated Monoclonal antibodies in the Rat: Influence of Tumour Growth and Reticuloendothelial System Host Modulation

Lars Jacobsson

Acta Oncologica, 1989

View PDFchevron_right

Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograft

R. Kashi

International Journal of Cancer, 1989

View PDFchevron_right

188ReDirect Labeling of Monoclonal Antibodies for Radioimmunotherapy of Solid Tumors: Biodistribution, Normal Organ Dosimetry, and Toxicology

Normando Iznaga

Nuclear Medicine and Biology, 1998

View PDFchevron_right

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice

S. Gnesin

EJNMMI Research, 2019

View PDFchevron_right

Current status of cancer immunodetection with radiolabeled human monoclonal antibodies

Robert de Jager

Seminars in Nuclear Medicine, 1993

View PDFchevron_right

[Radiolabeled antibodies for cancer treatment]

Jacques Barbet

Médecine sciences : M/S, 2009

View PDFchevron_right

Radiolabeled Immunoglobulin Therapy for Patients with Solid Tumors

Huib Vriesendorp

Journal of Nuclear Medicine & Radiation Therapy

View PDFchevron_right

RADIOLABELED ANTIBODY TUMOR DOSIMETRY

Sven-erik Strand

2000

View PDFchevron_right

Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin

H. Lena

British Journal of Cancer, 1995

View PDFchevron_right

Experimental studies on the role of antibody fragments in cancer radio‐immunotherapy: Influence of radiation dose and dose rate on toxicity and anti‐tumor efficacy

Heinz Schmidberger

International Journal of Cancer, 1998

View PDFchevron_right

Effects of Radiolabeling Monoclonal Antibodies with a Residualizing Iodine Radiolabel on the Accretion of Radioisotope in Tumors1

Amartya Basu

2000

View PDFchevron_right

Strategies for enhancement of radioimmunotherapy

David Kukis

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991

View PDFchevron_right

Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation

Haralabos Kalofonos

Cancer research, 1990

View PDFchevron_right

Improved radioimmunoimaging of human tumor xenografts by a mixture of monoclonal antibody F(ab')2 fragments

Abass Alavi

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986

View PDFchevron_right

Current status of radioimmunotherapy

Chaitanya Divgi

Nuclear Medicine and Biology, 1994

View PDFchevron_right